Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionFerguson Wellman Capital Management, Inc
Latest Disclosed Ownership27,077 shares
Latest Disclosed Value $ 2,168,326
Ferguson Wellman Capital Management, Inc reports 0.69% increase in ownership of EW / Edwards Lifesciences Corporation

On May 1, 2026 - Ferguson Wellman Capital Management, Inc filed a 13F-HR form disclosing ownership of 27,077 shares of Edwards Lifesciences Corporation (MX:EW) valued at $2,168,326 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 13, 2026 disclosing 26,892 shares of Edwards Lifesciences Corporation. This represents a change in shares of 0.69% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F Edwards Lifesciences CP COM 28176E108 27,077 185 0.69 2,168 -5.41 0.0201
2026-01-13 2025-12-31 13F Edwards Lifesciences CP COM 28176E108 26,892 -67 -0.25 2,293 9.35 0.0367
2025-10-23 2025-09-30 13F Edwards Lifesciences CP COM 28176E108 26,959 0 0.00 2,097 -0.57 0.0340
2025-07-10 2025-06-30 13F Edwards Lifesciences CP COM 28176E108 26,959 0 0.00 2,108 7.94 0.0371
2025-04-16 2025-03-31 13F Edwards Lifesciences CP COM 28176E108 26,959 -733 -2.65 1,954 -4.73 0.0379
2025-01-29 2024-12-31 13F Edwards Lifesciences CP COM 28176E108 27,692 718 2.66 2,050 15.17 0.0390
2024-11-06 2024-09-30 13F/A-1 Edwards Lifesciences CP COM 28176E108 26,974 -1,200 -4.26 1,780 -31.59 0.0345
2024-10-18 2024-09-30 13F Edwards Lifesciences CP COM 28176E108 26,959 -1,215 1,779 0.0375
2024-07-16 2024-06-30 13F Edwards Lifesciences CP COM 28176E108 28,174 -150 -0.53 2,602 -3.84 0.0529
2024-04-09 2024-03-31 13F Edwards Lifesciences CP COM 28176E108 28,324 -50 -0.18 2,707 25.10 0.0552
2024-01-11 2023-12-31 13F Edwards Lifesciences CP COM 28176E108 28,374 0 0.00 2,164 10.08 0.0485
2023-10-12 2023-09-30 13F Edwards Lifesciences CP COM 28176E108 28,374 -155 -0.54 1,966 -26.98 0.0481
2023-07-11 2023-06-30 13F Edwards Lifesciences CP COM 28176E108 28,529 84 0.30 2,691 14.36 0.0632
2023-04-20 2023-03-31 13F Edwards Lifesciences CP COM 28176E108 28,445 -61 -0.21 2,353 117,550.00 0.0591
2023-01-13 2022-12-31 13F Edwards Lifesciences CP COM 28176E108 28,506 0 0.00 2 -99.92 0.0554
2022-10-17 2022-09-30 13F Edwards Lifesciences CP COM 28176E108 28,506 -409 -1.41 2,355 -14.36 0.0921
2022-07-14 2022-06-30 13F Edwards Lifesciences CP COM 28176E108 28,915 -61 -0.21 2,750 -19.38 0.1019
2022-04-14 2022-03-31 13F Edwards Lifesciences CP COM 28176E108 28,976 82 0.28 3,411 -8.87 0.1074
2022-01-10 2021-12-31 13F Edwards Lifesciences CP COM 28176E108 28,894 -393 -1.34 3,743 12.88 0.1091
2021-10-22 2021-09-30 13F Edwards Lifesciences CP COM 28176E108 29,287 0 0.00 3,316 9.33 0.1070
2021-07-12 2021-06-30 13F Edwards Lifesciences CP COM 28176E108 29,287 -13 -0.04 3,033 23.75 0.0988
2021-04-26 2021-03-31 13F Edwards Lifesciences CP COM 28176E108 29,300 0 0.00 2,451 -8.31 0.0852
2021-02-04 2020-12-31 13F Edwards Lifesciences CP COM 28176E108 29,300 -910 -3.01 2,673 10.87 0.0653
2020-10-13 2020-09-30 13F Edwards Lifesciences CP COM 28176E108 30,210 0 0.00 2,411 15.47 0.0665
2020-08-04 2020-06-30 13F Edwards Lifesciences CP COM 28176E108 30,210 20,048 197.28 2,088 8.92 0.0638
2020-04-21 2020-03-31 13F Edwards Lifesciences CP COM 28176E108 10,162 0 0.00 1,917 -19.15 0.0720
2020-01-24 2019-12-31 13F Edwards Lifesciences CP COM 28176E108 10,162 -10 -0.10 2,371 5.99 0.0698
2019-10-15 2019-09-30 13F Edwards Lifesciences CP COM 28176E108 10,172 0 0.00 2,237 19.05 0.0714
2019-07-16 2019-06-30 13F Edwards Lifesciences CP COM 28176E108 10,172 -219 -2.11 1,879 -5.48 0.0624
2019-04-11 2019-03-31 13F Edwards Lifesciences CP COM 28176E108 10,391 0 0.00 1,988 24.87 0.0676
2019-01-16 2018-12-31 13F Edwards Lifesciences CP COM 28176E108 10,391 0 0.00 1,592 -12.00 0.0611
2018-10-25 2018-09-30 13F Edwards Lifesciences CP COM 28176E108 10,391 -120 -1.14 1,809 18.24 0.0594
2018-08-09 2018-06-30 13F Edwards Lifesciences CP COM 28176E108 10,511 -50 -0.47 1,530 3.87 0.0535
2018-04-09 2018-03-31 13F Edwards Lifesciences CP COM 28176E108 10,561 202 1.95 1,473 26.11 0.0523
2018-01-24 2017-12-31 13F Edwards Lifesciences CP COM 28176E108 10,359 145 1.42 1,168 4.66 0.0403
2017-10-11 2017-09-30 13F Edwards Lifesciences CP COM 28176E108 10,214 438 4.48 1,116 -3.46 0.0403
2017-07-26 2017-06-30 13F Edwards Lifesciences CP COM 28176E108 9,776 0 0.00 1,156 25.65 0.0434
2017-04-24 2017-03-31 13F Edwards Lifesciences CP COM 28176E108 9,776 0 0.00 920 0.44 0.0354
2017-02-01 2016-12-31 13F Edwards Lifesciences CP COM 28176E108 9,776 56 0.58 916 -21.84 0.0373
2016-10-24 2016-09-30 13F Edwards Lifesciences CP COM 28176E108 9,720 0 0.00 1,172 20.95 0.0501
2016-07-15 2016-06-30 13F Edwards Lifesciences CP COM 28176E108 9,720 -400 -3.95 969 8.51 0.0407
2016-04-20 2016-03-31 13F Edwards Lifesciences CP COM 28176E108 10,120 0 0.00 893 11.76 0.0380
2016-01-26 2015-12-31 13F Edwards Lifesciences CP COM 28176E108 10,120 5,060 100.00 799 11.13 0.0329
2015-11-03 2015-09-30 13F Edwards Lifesciences CP COM 28176E108 5,060 0 0.00 719 -0.28 0.0319
2015-07-28 2015-06-30 13F Edwards Lifesciences CP COM 28176E108 5,060 0 0.00 721 0.00 0.0298
2015-05-01 2015-03-31 13F Edwards Lifesciences CP COM 28176E108 5,060 5,060 0.00 721 0.0297
2015-01-27 2014-12-31 13F Edwards Lifesciences CP COM 28176E108 0 -5,060 -100.00 0 -100.00
2014-11-04 2014-09-30 13F Edwards Lifesciences CP COM 28176E108 5,060 60 1.20 517 20.51 0.0220
2014-07-25 2014-06-30 13F Edwards Lifesciences CP COM 28176E108 5,000 -120 -2.34 429 12.89 0.0181
2014-04-25 2014-03-31 13F Edwards Lifesciences CP COM 28176E108 5,120 0 0.00 380 12.76 0.0169
2014-01-28 2013-12-31 13F Edwards Lifesciences CP COM 28176E108 5,120 0 0.00 337 -5.60 0.0152
2013-10-22 2013-09-30 13F Edwards Lifesciences CP COM 28176E108 5,120 0 0.00 357 3.78 0.0177
2013-08-06 2013-06-30 13F Edwards Lifesciences CP COM 28176E108 5,120 5,120 344 0.0265
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.